Visual Performance of Bilateral AcrySof ReSTOR Aspheric +4

Determine the clinical visual outcomes following bilateral implantation of the AcrySof ReSTOR Aspheric Intraocular Lens (IOL) and to demonstrate what percentage of the subjects obtain spectacle freedom.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cataract Eye Diseases Lens Diseases

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Contact Alcon Call Center for Trial Locations

Fort Worth, Texas, 76134, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosed with cataracts

Exclusion criteria

Preexisting conditions confounding results; > 1 Diopter preoperative astigmatism

Treatment and study plan

AcrySof ReSTOR Aspheric +4

Device

Implantation with the AcrySof ReSTOR Aspheric +4 Multifocal Intraocular Lens (IOL)

Primary outcomes

Visual Acuity

Time frame: 6 months

Secondary outcomes

Contrast sensitivity, patient survey

Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Alcon Research

Industry

Registry information

Important dates

Study start: 2007
Primary completion: 2008
Study completion: 2008
First posted: Oct 5, 2010
Registry last updated: Oct 5, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed